10/28/2026
Here is the answer to yesterday's "What's Your Diagnosis?"!
Diagnosis: Equine Recurrent Uveitis
Dot most likely has Equine Recurrent Uveitis (ERU). ERU is a very complex eye disease that is the most common cause for vision loss in horses. ERU is characterized by recurrent episodes of inflammation of the uvea or middle part of the eye.
Although the exact cause of uveitis is unknown, it is thought to be an auto-immune condition that is initially triggered by systemic infections, trauma to the eye, or other environmental factors. Diagnosis is made based on thorough ophthalmic exam and recurrence of symptoms. Acute signs of uveitis include eye pain (squinting, tearing, rubbing), redness of the eye, eye swelling, corneal edema (blue haziness) and sensitivity to light.
Overtime, chronic uveitis can cause changes to the iris (colored part of the eye), cataract formation, glaucoma, shrinking of the eye, and damage to the retina that can lead to vision loss. Since ERU is considered an autoimmune disease, there are certain breeds that are predisposed to developing ERU. These breeds include Appaloosas, European Warmbloods, Paints, and draft breeds. In Appaloosa horses, the LP gene that dictates white spotting patterns plays a part in the risk of developing ERU.
Although ERU cannot be cured, treatment goals revolve around treating flares to reduce damage to the eye and preserve vision. Initial treatments usually include oral banamine and topical steroid eye ointment during bouts of inflammation. For many horses, conservative treatment during bouts of inflammation is enough to keep the uveitis under control. For horses that have more severe ERU or more regular occurrences, other treatments can be considered. More intense treatments include implantation of extended release immunosuppressant medications into the eye or injection of Gentamicin into the eye. If symptoms of ERU become too intense, treatments are becoming too frequent, or if the horse is in too much discomfort, enucleation or removal of the affected eye or eyes is also an option.